Search results
Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data
Zacks via Yahoo Finance· 2 days agoVerastem (VSTM) gains 57% post-market on achieving a confirmed partial response in 83% of first-line...
BioLineRx reports positive pancreatic cancer trial results By Investing.com
Investing.com· 2 days agoBioLineRx Ltd. (NASDAQ: BLRX), a biopharmaceutical company, announced encouraging results from the...
...Clinical Trial Evaluating Motixafortide in First-Line Pancreatic Cancer (PDAC) at American...
FOX 23 News Albany· 2 days agoThe CheMo4METPANC trial is evaluating the company's CXCR4 inhibitor motixafortide, the PD-1...
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and...
FOX 23 News Albany· 2 days agoOne is a trial-in-progress abstract discussing cohort 5 of the GOBLET study, which will evaluate the combination of pelareorep and modified FOLFIRINOX (mFOLFIRINOX) with and without atezolizumab ...
KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid...
Nature· 2 days agoInactivated suppressor of mothers against decapentaplegic homolog (SMAD) 4 significantly affects cancer development in pancreatic ductal adenocarcinoma ...
Bob Nunnally reveals to NBC4 viewers what type of cancer he had
WCMH via Yahoo News· 2 days agoCOLUMBUS, Ohio (WCMH) — Bob Nunnally knows the difference between himself and the superhero...
Alligator Bioscience To Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO...
Morningstar· 2 days agoOPTIMIZE-1 study results showed confirmed ORR of 40.4%, unconfirmed ORR of 50.9% and DCR of 79% in 57 evaluable patients with chemotherapy-naïve mPDACThe encouraging duration of response (median ...
Genetic cancer screening: Learning more about lesser known hereditary cancers
WTAE Pittsburgh· 6 days agoAccording to the National Cancer Institute, these inherited variants are thought to contribute to...
Urine Tests Could Be 'Enormous Step' in Diagnosing Cancer
Medscape· 5 days agoThe next frontier in cancer detection could be the humble urine test. Emerging science suggests that...
Oncofetal SNRPE promotes HCC tumorigenesis by regulating the FGFR4 expression through alternative...
Nature· 22 hours agoSNRPE-regulated alternative splicing was recognized by RNA-Seq and confirmed by multiple assays. We herein identified SNRPE as a crucial oncofetal splicing factor, significantly associated with ...